This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2006-2010.
Company Filing History:
Years Active: 2006-2010
Title: Thomas Giller: Innovator in Guanidine Derivatives
Introduction
Thomas Giller is a notable inventor based in Wintersingen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his work on guanidine derivatives. With a total of 3 patents, Giller's innovations focus on addressing various medical conditions, including pain management and addiction treatment.
Latest Patents
Giller's latest patents include groundbreaking work on guanidine derivatives and their use as neuropeptide FF receptor antagonists. These inventions relate to compounds that exhibit a neuropeptide FF receptor antagonist effect, which can be utilized in the treatment of pain, hyperalgesia, and withdrawal symptoms associated with alcohol, psychotropic drugs, and nicotine dependencies. The compounds are also designed to regulate insulin excretion, food intake, memory functions, blood pressure, electrolyte balance, and energy management, as well as to treat urinary incontinence. The methods for producing these compounds are based on generally accepted pharmaceutical practices.
Career Highlights
Throughout his career, Thomas Giller has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Actelion Pharmaceuticals Ltd and Grünenthal GmbH. His work in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
Giller has collaborated with esteemed colleagues, including Volker Breu and Kurt Hilpert. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Thomas Giller's contributions to the field of pharmaceuticals through his innovative work on guanidine derivatives highlight his role as a significant inventor. His patents not only address critical health issues but also pave the way for future advancements in medical treatments.